• Chlorthalidone Tablets

    Free

    Product Composition & Strength

    We supply this product as a Precision-Blended, High-Bioavailability Tablet, packed in moisture-resistant Alu-PVC or Alu-Alu blister strips to ensure the stability of the micronized active ingredient.

    Active IngredientStrengthPrimary Clinical Function
    Chlorthalidone USP/BP6.25 mg / 12.5 mgThe Contemporary Starting Dose: Highly preferred for modern “Low-Dose” hypertension therapy to maximize pressure control while minimizing electrolyte loss.
    Chlorthalidone USP/BP25 mgThe High-Potency Payload: Utilized for resistant hypertension or the management of edema associated with heart failure or hepatic cirrhosis.
    ExcipientsMicrocrystalline Cellulose / Colloidal Silicon Dioxide / Magnesium Stearate / Pregelatinized StarchDiluent / Glidant / Lubricant / Binder (Engineered specifically utilizing Micronized API Technology to ensure absolute uniformity in the 6.25mg and 12.5mg ultra-low-dose tablets, guaranteeing consistent renal response across every batch).
  • DAPAGLIFLOZIN TABLETS

    Free

    Product Composition & Strength

    We supply this product as a Precision-Blended, Hydrolytically Shielded Microdose Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical stability of the sensitive propanediol monohydrate active ingredient.

    Active IngredientStrengthPrimary Clinical Function
    Dapagliflozin (as Propanediol Monohydrate) USP/Ph.Eur.5 mgThe Titration & Hepatic Anchor: The definitive starting dose utilized for patients with severe hepatic impairment or those at high risk for volume depletion (hypotension).
    Dapagliflozin (as Propanediol Monohydrate) USP/Ph.Eur.10 mgThe Cardio-Renal Macrodose: The massive, globally standardized therapeutic payload required for the aggressive, daily maintenance of Heart Failure, CKD, and Type 2 Diabetes.
    ExcipientsMicrocrystalline Cellulose / Anhydrous Lactose / Crospovidone / Silicon Dioxide / Magnesium Stearate / Premium Polymeric FilmDiluent / Densifier / Superdisintegrant / Glidant / Heavy Film-Coating (Engineered specifically utilizing Strict Low-Humidity Granulation to prevent the highly sensitive API from degrading during compression, sealed with an impenetrable film-coat to block environmental moisture and ensure rapid gastric dissolution)

    *Pack Sizes: 10×10 Alu-Alu Blisters or 14/28-Tablet Calendar Packs (Optimized specifically for strict chronic cardio-renal dispensing regimens).

  • Furosemide & Spironolactone Tablets

    Free

    Product Composition & Strength

    We supply this product as a Precision-Blended, High-Density Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-PVC or Alu-Alu blister strips to ensure the absolute chemical stability of both active pharmaceutical ingredients.

    Active IngredientStrengthPrimary Clinical Function
    Furosemide USP/Ph.Eur.20 mgThe Loop Diuretic (Fluid Clearance): Rapidly eliminates severe fluid buildup (edema) from the lungs, abdomen, and peripheral tissues.
    Spironolactone USP/Ph.Eur.50 mgThe Potassium-Sparing Shield: Blocks aldosterone, prevents toxic cardiac fibrosis, and heavily protects the patient against lethal hypokalemia.
    ExcipientsMicrocrystalline Cellulose / Lactose Monohydrate / Sodium Starch Glycolate / Povidone K-30 / Magnesium Stearate / Premium Polymeric FilmDiluent / Binder / Superdisintegrant / Slipper-Coating (Engineered utilizing advanced wet-granulation to ensure both the rapid-acting Furosemide and the slower-acting Spironolactone dissolve at precise, synchronized rates to guarantee the electrolyte-sparing synergy)

    *Pack Sizes: 10×10 Blisters (Optimized specifically for strict chronic cardiology and hepatology dispensing regimens).

  • Glibenclamide, Metformin & Pioglitazone Tablets

    Free

    Product Composition & Strength

    We supply this product as a Precision-Blended, High-Density Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical stability of the three highly reactive APIs.

    Active IngredientStrengthPrimary Clinical Function
    Glibenclamide USP/Ph.Eur.5 mgThe Secretagogue (Micro-Dose): Triggers rapid, potent insulin release from the pancreas to control acute post-prandial (after-meal) glucose spikes.
    Pioglitazone (as Hydrochloride) USP/Ph.Eur.15 mgThe Sensitizer (Micro-Dose): Reverses deep cellular insulin resistance in skeletal muscle and adipose tissue.
    Metformin Hydrochloride USP/Ph.Eur.500 mg (IR or ER)The Hepatic Anchor (Macro-Dose): Provides baseline suppression of liver glucose production. Frequently formulated in a sustained-release matrix to minimize severe GI side effects.
    ExcipientsMicrocrystalline Cellulose / Croscarmellose Sodium / Hypromellose / Magnesium Stearate / Premium Opadry FilmDiluent / Superdisintegrant / Binder (ER Polymer) / Lubricant (Engineered utilizing elite multi-stage geometric dilution to guarantee that the lethal 5mg micro-dose of Glibenclamide is flawlessly and evenly distributed throughout the massive 500mg Metformin matrix)

    *Pack Sizes: 10×10 Alu-Alu Blisters (Optimized specifically for strict, chronic diabetic dispensing regimens).

  • Ivabradine HCL Tablets

    Free

    Product Composition & Strength

    We supply this product as a Precision-Blended, High-Density Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical stability of the highly hygroscopic hydrochloride salt.

    Active IngredientStrengthPrimary Clinical Function
    Ivabradine (as Hydrochloride) USP/Ph.Eur.5 mgInitiation / Titration Standard: Base therapeutic unit utilized twice daily for the safe initiation of therapy, allowing the cardiologist to monitor resting heart rate before upward titration.
    Ivabradine (as Hydrochloride) USP/Ph.Eur.7.5 mgGlobal Maintenance Standard: High-efficacy adult maintenance dose to strictly maintain the resting heart rate between 50 and 60 beats per minute.
    ExcipientsLactose Monohydrate / Maize Starch / Maltodextrin / Colloidal Silicon Dioxide / Magnesium Stearate / Premium Opadry FilmDiluent / Binder / Glidant / Lubricant / Film-Coating (Engineered specifically using precise geometric dilution to ensure the micro-dose API is flawlessly distributed, preventing accidental bradycardia from “hot spots” in a poorly blended generic tablet)

    *Pack Sizes: 10×10 Blisters or Bottles of 56 (Optimized specifically for strict 28-day chronic cardiology dispensing regimens).

  • METOPROLOL + RAMIPRIL TABLETS

    Free

    Product Composition & Strength

    We supply this product as a Precision-Engineered, API-Segregated Bilayer Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical stability of the highly degradable Ramipril molecule.

    Active IngredientStrengthPrimary Clinical Function
    Metoprolol (as Succinate/Tartrate) Ph.Eur./USP25 mg / 50 mgCardioselective Base: Reduces heart rate, cardiac output, and myocardial oxygen demand; protects against sudden cardiac death.
    Ramipril Ph.Eur./USP2.5 mg / 5 mgACE Inhibitor Driver: Forces profound systemic vasodilation, protects the kidneys (renoprotection), and halts pathological cardiac remodeling.
    ExcipientsMicrocrystalline Cellulose / Sodium Stearyl Fumarate / Hypromellose / Sodium Bicarbonate / Iron Oxide ColorsLow-Moisture Diluent / Lubricant / Film-Coating / Polymeric Stabilizer (Engineered specifically to physically isolate the acidic Ramipril from cross-reacting with the Metoprolol salt, preventing the formation of toxic diketopiperazine impurities)

    *Pack Sizes: 10×10 Alu-Alu Blisters (Optimized specifically for strict 30-day chronic cardiology dispensing regimens).

  • Nebivolol Tablets

    Free

    Product Composition & Strength

    We supply this product as a Precision-Blended, Low-Dose Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu or high-density PVC/PVDC blister strips to ensure the absolute chemical stability of the hydrochloride salt.

    Active IngredientStrengthPrimary Clinical Function
    Nebivolol (as HCl) Ph.Eur./USP2.5 mg / 5 mgGlobal Hypertension Standard: Base therapeutic unit for the continuous, highly tolerated management of essential hypertension.
    Nebivolol (as HCl) Ph.Eur./USP10 mg / 20 mgAdvanced Cardiac Standard: High-dose maintenance therapy for refractory hypertension and specialized heart failure protocols.
    ExcipientsLactose Monohydrate / Microcrystalline Cellulose / Croscarmellose Sodium / Hypromellose / Polysorbate 80 / Magnesium StearateDiluent / Superdisintegrant / Wetting Agent / Lubricant (Engineered specifically to ensure rapid, predictable gastric dissolution while protecting the delicate racemic balance of the API)

    *Pack Sizes: 10×10 Blisters or 28/30-Tablet Calendar Packs (Optimized specifically for strict, high-compliance chronic cardiology dispensing regimens).

  • Torsemide Tablet

    Free

    Torsemide tablets (also spelled Torasemide) primarily contain Torsemide as the active pharmaceutical ingredient. It is a potent loop diuretic, often referred to as a “water pill,” used to treat high blood pressure and fluid retention (edema) caused by heart, kidney, or liver disease.